DNA4Life announced the launch of their Pharmacogenetic Report, a genetic test that can analyze a patient’s DNA to predict their response commonly prescribed medications across therapeutic classes.

The DNA4Life Pharmacogenetic Report evaluates 12 of the most common genes linked to drug metabolism and response; this information is then compared with more than 120 of the most frequently prescribed drugs from multiple therapeutic classes. The online physician-integrated ordering system and requirement that patients share their results with their clinician ensures that patients receive the appropriate medical context and support with this information.

RELATED: Single DNA Change Can Affect Diabetes Drug Response

Additional reports are also under development, including those to evaluate wellness, dermatology, and women’s health. The DNA4Life Pharmacogenetic Report retails for $249 and can be ordered from the company website.

For more information visit DNA4Life.com.